Similar articles for PMID: 35790278

Year	Number of Results
2016	2
2017	8
2018	4
2019	17
2020	33
2021	26
2022	21
2023	1
2024	0

1

Evaluation of Durvalumab-induced Lung Toxicity Using a Spontaneous Reporting Database.

Sato J, Nakano K, Shimizu T, Uchida M. Sato J, et al. Anticancer Res. 2022 Jul;42(7):3575-3582. doi: 10.21873/anticanres.15844. Anticancer Res. 2022. PMID: 35790278

2

Durvalumab for patients with unresectable stage III non-small cell lung cancer and grade 1 radiation pneumonitis following concurrent chemoradiotherapy: a multicenter prospective cohort study.

Sugimoto T, Fujimoto D, Sato Y, Tamiya M, Yokoi T, Tamiya A, Iwasawa S, Hata A, Uchida J, Fukuda Y, Hara S, Kanazu M, Hirano K, Kokubo M, Yamamoto N. Sugimoto T, et al. Invest New Drugs. 2021 Jun;39(3):853-859. doi: 10.1007/s10637-020-01060-8. Epub 2021 Jan 6. Invest New Drugs. 2021. PMID: 33405089 Clinical Trial.

3

Real-World Incidence of Pneumonitis in Patients Receiving Durvalumab.

LeClair JN, Merl MY, Cohenuram M, Luon D. LeClair JN, et al. Clin Lung Cancer. 2022 Jan;23(1):34-42. doi: 10.1016/j.cllc.2021.08.006. Epub 2021 Aug 16. Clin Lung Cancer. 2022. PMID: 34556401

4

Chemoradiotherapy followed by durvalumab in patients with unresectable advanced non-small cell lung cancer: Management of adverse events.

Miura Y, Mouri A, Kaira K, Yamaguchi O, Shiono A, Hashimoto K, Nishihara F, Shinomiya S, Akagami T, Murayama Y, Abe T, Noda SE, Kato S, Kobayashi K, Kagamu H. Miura Y, et al. Thorac Cancer. 2020 May;11(5):1280-1287. doi: 10.1111/1759-7714.13394. Epub 2020 Mar 11. Thorac Cancer. 2020. PMID: 32160383 Free PMC article.

5

Characterizing immune-mediated adverse events with durvalumab in patients with unresectable stage III NSCLC: A post-hoc analysis of the PACIFIC trial.

Naidoo J, Vansteenkiste JF, Faivre-Finn C, Özgüroğlu M, Murakami S, Hui R, Quantin X, Broadhurst H, Newton M, Thiyagarajah P, Antonia SJ. Naidoo J, et al. Lung Cancer. 2022 Apr;166:84-93. doi: 10.1016/j.lungcan.2022.02.003. Epub 2022 Feb 9. Lung Cancer. 2022. PMID: 35245844 Free article.

6

Radiation pneumonitis in lung cancer patients treated with chemoradiation plus durvalumab.

Shaverdian N, Thor M, Shepherd AF, Offin MD, Jackson A, Wu AJ, Gelblum DY, Yorke ED, Simone CB 2nd, Chaft JE, Hellmann MD, Gomez DR, Rimner A, Deasy JO. Shaverdian N, et al. Cancer Med. 2020 Jul;9(13):4622-4631. doi: 10.1002/cam4.3113. Epub 2020 May 6. Cancer Med. 2020. PMID: 32372571 Free PMC article.

7

Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial.

Bozorgmehr F, Chung I, Christopoulos P, Krisam J, Schneider MA, Brückner L, Mueller DW, Thomas M, Rieken S. Bozorgmehr F, et al. BMC Cancer. 2020 Aug 26;20(1):806. doi: 10.1186/s12885-020-07264-8. BMC Cancer. 2020. PMID: 32842974 Free PMC article.

8

Evaluation of lung adverse events with trastuzumab using the Japanese pharmacovigilance database.

Kanbayashi Y, Uchida M, Kashiwagi M, Akiba H, Shimizu T. Kanbayashi Y, et al. Med Oncol. 2022 Sep 29;39(12):219. doi: 10.1007/s12032-022-01805-w. Med Oncol. 2022. PMID: 36175697

9

Evaluation of Lung Toxicity Related to the Treatment With Alectinib Using a Pharmacovigilance Database.

Sato J, Uchida M, Wakabayashi H, Shimizu T. Sato J, et al. Anticancer Res. 2022 Jun;42(6):3109-3116. doi: 10.21873/anticanres.15799. Anticancer Res. 2022. PMID: 35641286

10

Predicting factors of symptomatic radiation pneumonitis induced by durvalumab following concurrent chemoradiotherapy in locally advanced non-small cell lung cancer.

Mayahara H, Uehara K, Harada A, Kitatani K, Yabuuchi T, Miyazaki S, Ishihara T, Kawaguchi H, Kubota H, Okada H, Ninomaru T, Shindo C, Hata A. Mayahara H, et al. Radiat Oncol. 2022 Jan 15;17(1):7. doi: 10.1186/s13014-021-01979-z. Radiat Oncol. 2022. PMID: 35033139 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

99 results

Results by year